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In patients with osteomalacia, a defect in bone mineralization leads to changed char-
acteristics of the bone surface. Considering that the properties of the surrounding 
matrix influence function and differentiation of cells, we aimed to investigate the ef-
fect of osteoidosis on differentiation and function of osteoclasts. Based on osteoma-
lacic bone biopsies, a model for osteoidosis in vitro (OIV) was established. Peripheral 
blood mononuclear cells were differentiated to osteoclasts on mineralized surfaces 
(MS) as internal control and on OIV. We observed a significantly reduced number 
of osteoclasts and surface resorption on OIV. Atomic force microscopy revealed a 
significant effect of the altered degree of mineralization on surface mechanics and 
an unmasking of collagen fibres on the surface. Indeed, coating of MS with RGD 
peptides mimicked the resorption phenotype observed in OIV, suggesting that the 
altered differentiation of osteoclasts on OIV might be associated with an interaction 
of the cells with amino acid sequences of unmasked extracellular matrix proteins 
containing RGD sequences. Transcriptome analysis uncovered a strong significant 
up-regulation of transmembrane glycoprotein TROP2 in osteoclastic cultures on OIV. 
TROP2 expression on OIV was also confirmed on the protein level and found on 
the bone surface of patients with osteomalacia. Taken together, our results show a 
direct influence of the mineralization state of the extracellular matrix surface on dif-
ferentiation and function of osteoclasts on this surface which may be important for 
the pathophysiology of osteomalacia and other bone disorders with changed ratio of 
osteoid to bone.
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1  | INTRODUC TION
Normal bone function requires bone remodelling that is a life-
long and complex process involving bone formation and bone 
resorption. During this, the osteoclast plays a pivotal role due to 
its unique ability of bone resorption. Osteoclasts belong to the 
mononuclear phagocyte system and originate from HSCs through 
differentiation of CD14+ monocytes.1,2 During differentiation, 
osteoclastogenesis requires two essential factors: macrophage 
colony-stimulating factor (M-CSF) and receptor activation of 
NF-kB ligand (RANKL). M-CSF mainly promotes proliferation and 
survival of osteoclast precursors. RANKL is known to function as 
the primary factor driving differentiation of osteoclast precursors 
by controlling gene expression by activating its receptor RANK. 
Secondary, osteoclast function highly depends on bone-cell inter-
action and its cytoskeleton organization. Bone-cell interaction is 
mediated by integrin avß3 which recognizes the RGD sequence 
that is present in various bone matrix proteins. Interaction of inte-
grin avß3 with the bone matrix induces cytoskeleton organization 
that leads to polarization of the osteoclast and establishment of 
the typical resorptive compartment.3 Any imbalance in the regu-
lation of bone remodelling can result in a metabolic bone disease 
like osteoporosis, osteopetrosis, osteosclerosis, pycnodysostosis 
or osteomalacia.4-9
Vitamin D deficiency, in particular, is an increasingly important 
global health problem across all ages. It leads to changes in the me-
tabolism of calcium that eventually result in decreased mineralization 
of bone.10 Based on histological findings, accumulation of unminer-
alized bone tissue (osteoid) is referred to as osteoidosis. According to 
Parfitt, the resulting condition with a ratio of osteoid volume to bone 
volume >10% is called osteomalacia.11
In a cross-sectional study of a normal German population, os-
teomalacia occurred in more than 25%, independent of the subjects 
age.12 The degree of mineralization largely determines the stiffness 
of a tissue. Thus, osteoidosis leads to a decreased elastic modulus 
(Young's modulus) of the affected bone surface.13 Therefore, it can 
be supposed that the matrix mechanics for the bone cells which are 
attached to the bone surface are modified by this disorder. For a vari-
ety of cells, it has already been shown that the matrix properties can 
influence cellular functions, including cell proliferation, locomotion, 
adhesion, spreading, morphology, striation and differentiation.14-20 
For haematopoietic stem cells (HSCs) in particular, Lee-Thedieck 
et al have shown that their migration and adhesion behaviour are 
dependent on the elastic modulus of the substrate. Similar effects 
are reported by Holst et al who described an altered proliferation 
behaviour of HSCs caused by an altered Young's modulus of the sur-
rounding substrate.21,22
If the differentiation of HSCs can be influenced by the sub-
strate's elasticity, we have been suggested that the differen-
tiation and function of osteoclasts might also be influenced by 
changes of the bone surface. Therefore, we investigated the ef-
fect of matrix mineralization on the differentiation and function 
of osteoclasts.
2  | MATERIAL S AND METHODS
2.1 | Morphometric analysis of osteomalacia
After fixation in buffered formalin, the tissues were embedded un-
decalcified in methyl-methacrylate, cut into sections of 5 µm thick-
ness using a k-microtome (Jung) and stained with Goldner trichrome 
staining. The retrospective analysis of patient's records was per-
formed in compliance with the Hamburg Hospital Law, Germany 
(HmbKHG, Version: 17th of April, 1991; Second chapter: Patients 
data protection, Paragraph 12).
2.2 | In vitro model of mineralized tissue and OIV
Dentin is widely used as a model for mineralized tissue. It was pro-
vided by German customs in accordance with the international laws 
for the protection of species. Discs of 10.0 × 10.0 × 0.7 mm were 
prepared by using a diamond saw (PSI Grünewald GmbH & Co. KG). 
Physiologically mineralized dentin discs (Mineralized surface, MS) 
were served as control. To generate an unmineralized matrix and imi-
tate an osteoidosis (OIV), the surface of dentin discs was demineral-
ized by immersion in one molar hydrochloric acid (Carl Roth GmbH & 
Co. KG) for 1 minute. After demineralization, the dentin was washed 
thoroughly with distilled water and stored at room temperature (RT) 
until its use in cell culture.
2.3 | Preparation of RGD peptide-coated dentin
Dentin discs were prepared as described above. The cyclic RGD pep-
tide c(RGDfK) (RGD, Novabiochem) was solubilized in MilliQ water 
(Merck MilliPore) to give a concentration of 100 µmol/L. Each disc 
was covered with 500 µL RGD solution and incubated for 10 min-
utes under ambient conditions. Finally, discs were cleaned with 
100% isopropanol for 5 minutes and dried for 3 hours inside the 
laminar flow hood.
2.4 | Atomic force microscopy
Atomic force microscopy (AFM) measurements were carried out 
as previously described.23 Measurements were carried out on a 
NanoWizard AFM (JPK Instruments) combined with an Axiovert 
200 inverted optical microscope (Carl Zeiss AG). For contact mode 
imaging and elasticity measurements, sharp pyramidal silicon nitride 
cantilevers (MLCT Microcantilever, Bruker) with 0.02 N/m nominal 
spring constant and tip half-opening angle of 17.5° were used. The 
force constant of each cantilever was determined individually using 
the thermal noise method. Images of the osteoidosis model and 
physiologically mineralized dentin discs were acquired in air with a 
scan rate of 1 Hz and a resolution of 512 × 512 pixels. All elasticity 
measurements were carried out for three different discs in PBS (pH 
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7.4). 25 × 25 indentation points over an image section of 10 × 10 µm 
were chosen, and force vs distance curves were recorded at 1 Hz. 
After converting force vs distance curves to force vs indentation 
curves, the Hertz model, modified for a pyramidal tip geometry, was 
used to extract the elastic modulus (Young's modulus) at each inden-
tation point.24
For conversion of force vs distance to force vs indentation 
curves, as well as Young's modulus extraction, the JPK Data 
Processing Software version 4.2.20 (JPK Instruments AG) was used. 
Finally, Igor Pro Software version 6.0.2.4 (WaveMetrics, Inc) was 
used to visualize the frequency distribution of measured Young's 
moduli in a histogram. The centre of the distribution was deter-
mined by fitting a Gaussian distribution to the data. For further 
analysis of the surface, the D-period of the collagen network was 
determined using cross-sectional AFM images and the Gwyddion 
Software 2.26.
2.5 | Cell culture of human osteoclasts
Peripheral blood mononuclear cells (PBMCs) were isolated from 
buffy coats of anonymous, healthy, voluntary blood donors, giving 
informed consent. Buffy coat is a waste product of the process of 
blood component manufacturing and was used in accordance with 
the ethical standards of the institutional research committee and 
with the 1964 Helsinki declaration and its later amendments. As de-
scribed previously, density gradient centrifugation with Ficoll-Paque 
was used to separate the mononuclear osteoclast precursor cells 
from other formed elements in the buffy coat. To dispose the culture 
of lymphocytes, the cells were purified for adherence. Cells were 
then cultivated at a density of 2 × 106 cells/mL on prepared dentin 
discs in alpha MEM containing 1% l-glutamine, 1% penicillin/strep-
tomycin/amphotericin (PAA Laboratories GmbH), 10% foetal calf 
serum (Gibco), 20 ng/mL M-CSF and 40 ng/mL RANKL (PeproTech 
GmbH) for up to 28 days.25
2.6 | TRAP staining and evaluation of 
osteoclast numbers
After 28 days of cultivation, cells on dentin discs were fixed with 
37% buffered formaldehyde and incubated with TRAP stain-
ing solution (Sigma Aldrich). Then, cells were analysed with the 
Eclipse TS 100 inverted optical microscope combined with a 
digital camera and the NIS-Elements BR software (Nikon GmbH). 
To determine the number of osteoclasts, cells positive for TRAP 
and with three or more nuclei were counted. The experiment 
was repeated for three times, each time including six individual 
replicates.
2.7 | Infinite focus microscopy
The three-dimensional resorption activity of osteoclasts on MS, OIV 
and RGD-coated dentin was quantified by infinite focus microscopy 
(IFM) as described by us previously.26 Briefly, cells were detached from 
the surface after 28 days of cultivation. For three-dimensional quan-
tification of the resorbed volume, three-dimensional surface data 
sets were generated with voxel sizes of 800 nm × 800 nm × 100 nm 
using IFM (InfiniteFocus Alicona). To minimize the effect of surface 
roughness on measured resorption, a roughness exclusion plane 
was defined as the mean of all depth values of the topographic sur-
face of the untreated material minus two times standard deviation. 
Only pits which were deeper than this roughness exclusion plane 
were included in the analysis. Pseudocolour visualization as well as 
computation of resorbed volume, resorbed area and depth was per-
formed with the built-in software in combination the freeware image 
analysis software (UTHSCSA Image Tool V 3.0). Measurements were 
repeated with three different samples for each surface topography.
2.8 | mRNA microarray analysis
Microarray analysis was performed after 28 days of cultivation using 
the Human Genome U133 Plus 2.0 Arrays (Affymetrix). Procedures 
for cDNA synthesis, labelling and hybridization were carried out ac-
cording to the manufacturer's protocol (Affymetrix). In brief, 50 ng 
of total RNA was used for first-strand cDNA synthesis with an 
HPLC-purified T7-(dT)24 primer. Synthesis of biotin-labelled cRNA 
and clean up was carried out using the IVT Express Kit (Affymetrix). 
For hybridization, 15 µg of fragmented cRNA was incubated with 
the chip in 200 µL of hybridization solution in Hybridization Oven 
640 (Affymetrix) at 45°C for 16 hours. GeneChips were then washed 
and stained using the Affymetrix Fluidics Station 450 according 
to the GeneChip Expression Analysis Technical Manual (Rev. 2). 
Microarrays were scanned with the Affymetrix GeneChip Scanner 
7G, and the signals were processed using GCOS (v.1.4; Affymetrix).
2.9 | Quantitative realtime PCR analysis
At day 28, RNA isolation was carried out using the High Pure RNA Cell 
Isolation Kit (Roche Diagnostics GmbH) following the manufacturer's 
instructions. RNA was then transcribed to cDNA in the iQ5 qPCR 
cycler by the use of 5× iScript RT Supermix (Bio-Rad Laboratories). 
For qPCR analysis, 2 ng of resulting cDNA of each probe was used. 
The performed PCR protocol was as follows: one step of 2 minutes at 
98°C, 40 primer-specific cycles of 10 seconds at 95°C and 30 seconds 
at 60°C, a melt curve was generated with 80 cycles of 6 seconds and 
a starting temperature of 65°C with 0.5°C increments.
Primer: TROP2 forward 5′-TGG CCT ACC CGA GGA GAA GAG 
GA-3′, reverse 3′-CGT TCA GGC AGC TGA AAC AGG CT-5′. The am-
plification of the housekeeping gene 28S rRNA, forward 5′-CGG TTT 
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TGG-5′, served as reference. In order to quantify the relative change of 
gene expression, the ΔΔCt-method was used. Thus ΔCt was calculated 
by normalizing the Ct (cycle of threshold) value to the 28S rRNA Ct 
value. Afterwards, the ratio of ΔCt (=2ΔCt) was determined to express 
the gene expression relative to 28S rRNA. qPCR analysis was repeated 
for three times. Each experiment included twelve replicates per group 
(mineralized dentin vs OIV) that were pooled prior to RNA isolation.
2.10 | TROP2 immunohistochemistry staining
Cells on MS and OIV were fixed with 3.7% formaldehyde. 
Afterwards, cells were incubated for 1 hour at RT with PBS con-
taining 10% BSA, followed by incubation of the primary antibody 
(Cat.: ab79976, Abcam GmbH) in 1% BSA in PBS (1:200) overnight. 
The next day, samples were incubated with the secondary antibody 
(Cat.: A11019, Life Technologies GmbH) in 1% BSA in PBS (1:1000). 
Finally, cells were counterstained using DAPI (DAPI, Cat.: P26931, 
Life Technologies GmbH) and pictures were taken with the fluores-
cence microscope Eclipse TE 2000-S (Nikon GmbH). Osteomalacia 
bone biopsies were subjected to the same procedure.
2.11 | Statistical analysis
All experiments were repeated for three times to allow statistical analy-
sis, except for the mRNA microarray, which was performed once with a 
pooled sample. Statistical analysis and the generation of graphics were 
performed using Sigma Plot software. For normally distributed data, one-
way ANOVA testing was performed, followed by Tukey post hoc testing, 
if there were more than two groups. For non-normally distributed data, 
Mann-Whitney rank sum test was performed. The probability of a type I 
error was set to 5% (α = .05). Error bars represent SD.
3  | RESULTS
3.1 | Model for osteoidosis in vitro
While we could not detect an osteoid seam in the bone biopsy of 
a healthy patient (Figure 1A), histomorphometric examination of 
bone biopsies from patients with osteomalacia showed an osteoid 
seam of 57.8 ± 6.9 µm (Figure 1B). In our dentin model (Osteoidosis 
in vitro, OIV), we generated an unmineralized seam that was in the 
same order of magnitude (Figure 1D; 56.5 ± 1.0 µm). In the control 
specimens (Mineralized surface, MS), no zone of unmineralized ma-
trix was detectable (Figure 1C).
3.2 | Surface analysis
To quantify the changes in surface properties, we analysed MS 
and OIV by atomic force microscopy. The comparison of the force 
curves of MS and OIV indicated a substantial difference in the 
material's rigidity (Figure 2A) which is illustrated by the force in-
crease which is much more pronounced on MS compared with 
OIV. Moreover, the Young's modulus of OIV was determined at 
366 ± 4.3 kPa (Figure 2B) by atomic force microscopy (AFM). The 
Young's modulus of MS was so much higher than OIV that it ex-
ceeded the calibrated range of our equipment Other research 
groups have determined the Young's modulus of mineralized den-
tin at 18-20 GPa.27-29 Thus, the unmineralized matrix in OIV leads 
to a decrease of tissue stiffness in the range of five powers of 
magnitude.
The comparison of AFM images further revealed the typical 
cross-striation of exposed collagen fibrils on OIV (Figure 2D). The 
AFM image of MS, on the other hand, showed no cross-striation 
(Figure 2C). The analysis of the D-period (data not shown) confirmed 
F I G U R E  1   Comparison of osteoid 
seam and OIV model. Goldner trichrome 
stained bone biopsies of a healthy 
individual (A) and an osteomalacia patient 
(B). The osteoid seam (B) is presented 
in red and marked by a black bar. The 
same staining was performed with the 
mineralized surface (C) and OIV model (D) 
to visualize the degree of mineralization. 
(Light microscopy, magnification 20×)
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the exposure of the collagen network due to demineralization. As ex-
pected, the distance between the collagen molecules was found to 
be 63.6 ± 3.6 nm.
3.3 | Effects on the number of osteoclasts
In comparison to MS (Figure 3A), there was a significantly lower num-
ber of differentiated osteoclasts after 28 days on OIV (Figure 3B); 
MS: 30.08 ± 8.60 osteoclasts/field of view vs OIV: 9.59 ± 1.88 os-
teoclasts/field of view, (Figure 3C, P = .03).
3.4 | Quantification of resorption activity
Three-dimensional quantification of osteoclastic resorption revealed 
a strong resorptive activity of osteoclasts on MS (Figure 4A,C, MS: 
80.15 ± 7.22%) while there was almost no resorption detectable on OIV 
F I G U R E  2   Surface mechanics. Force 
curves of MS and OIV (A) are shown. The 
histogram (B) depicts the distribution of 
the measured Young's modulus of OIV 
(curve corresponds to the Gaussian fit). 
Representative AFM images of MS (C) and 
OIV (D) are shown. The collagen network 
on OIV can be detected by the typical 
cross-striation of the exposed collagen 
fibres
F I G U R E  3   TRAP staining. TRAP+ 
multinucleated cells were detectable 
on MS (A, TRAP staining, magnification 
10×), cells on OIV were also TRAP+ but 
mainly mononuclear (B). The number of 
osteoclasts showed a threefold reduction 
on OIV (C, *P < .05)
5670  |     GRÜNHERZ Et al.
(Figure 4B,C, OIV: 3.54 ± 2.47%; P < .001). Interestingly, resorption depth 
of individual resorption pits was not significantly different between MS 
and OIV (Figure 4D, MS: 2.04 ± 1.15 µm vs OIV: 1.95 ± 0.83 µm; P = .896).
3.5 | Resorption activity on RGD peptide coating
As collagen is known to directly influence cell behaviour through its 
high level on RGD peptide, we coated MS with a very thin layer of 
RGD peptides, without detectable changes of the surface mechanics. 
Again, we found a strong reduction of resorption area on RGD-coated 
dentin (Figure 5C, MS = 18.5 ± 17.0% vs RGD = 5.9 ± 6.2%; P = .01), 
while the resorption depth on MS and RGD did not differ significantly 
(Figure 5D, MS = 3.1 ± 2.6 µm vs RGD = 5.5 ± 5.3 µm; P = .15).
3.6 | Analysis of gene expression
To find an explanation for the significantly lower number of osteo-
clasts as well as the decreased resorption area on OIV, whole genome 
microarray analysis was performed for both groups after 28 days of 
cultivation (Figure 6A). We identified the tumour-associated calcium 
signal transducer 2 (TROP2) to be the most strongly up-regulated 
gene on OIV compared with MS which was confirmed by qPCR analy-
sis (Figure 6B). On OIV, TROP2 showed a significant 15-fold up-reg-
ulation (Figure 6B, MS = 0.12 ± 0.06 vs OIV = 1.85 ± 2.15, P = .008).
3.7 | TROP2+ cells on osteoidosis in vitro
TROP2 staining of cells on MS and OIV confirmed our qPCR results 
on a protein level. While we could not detect TROP2 in osteoclast 
cultures on MS (Figure 6C), there was a strong expression in the cells 
on OIV (Figure 6D).
3.8 | TROP2+ osteoclasts in human osteomalacia
Given the presence of osteoid on the bone surface in healthy individu-
als as well as in patients with osteomalacia, the increased thickness and 
pathologic accumulation of osteoid in relation to the remaining bone 
volume are pathognomonic for osteomalacia. The staining revealed no 
expression of TROP2 on osteoclasts on the bone surface of a healthy 
individual (Figure 7A,B). However, a strong expression of TROP2 could 
be detected on cells on the surface of unmineralized bone in a patient 
with osteomalacia (Figure 7C,D), while most cells in the surrounding 
bone marrow were not positive for TROP2. This suggests bone-spe-
cific TROP2 expression in the context of osteomalacia.
4  | DISCUSSION
We show here that a change of matrix mineralization, which can 
be found in several metabolic bone diseases, alters the function 
and differentiation of osteoclasts in vitro. This is most likely due 
to an exposition of collagen fibrils resulting in an RGD-mediated 
pathway.
In our model system, we were able to generate a unmineralized 
seam that was of the same order of magnitude as that in bone biop-
sies from osteomalacia patients and consistent with Parfitt's defini-
tion of osteomalacia referring to a mean osteoid thickness above an 
absolute value of 12.5 µm.11
Although the same cell metabolic activity indicating a simi-
lar number of progenitor cells on OIV and MS was found at day 1 
F I G U R E  4   Resorption activity. 
Pseudocolour three-dimensional IFM 
images of MS (A) and OIV (B) show the 
distribution and depth of resorption pits. 
The bar charts represent a significant 
difference in surface resorption (C), 
whereas the resorption depth (D) showed 
no difference (***P < .001)
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(MTT-assay, Figure S1), the differentiation of human osteoclasts on 
OIV resulted in a significantly lower number of cells and a reduction 
of the resorbed surface.
Of note, the whole genome microarray revealed a 15-fold 
up-regulation of TROP2 expression on OIV while expression 
of osteoclastic differentiation markers was comparable for 
both groups (Figure S2). TROP 2 expression on OIV was fur-
ther confirmed on a protein level with immunohistochemis-
try in vitro and in patients with osteomalacia. TROP2 is a cell 
surface receptor that is highly expressed in trophoblast cells, 
F I G U R E  5   Resorption activity on 
RGD peptide coating. Pseudocolour 
three-dimensional IFM images of MS 
(A) and RGD-coated dentin (B) show the 
distribution and depth of resorption pits. 
The comparison of the surface resorption 
(C) revealed a statistically significant 
difference between MS and RGD, 
whereas the resorption depth (D) showed 
no difference (*P < .05)
F I G U R E  6   Expression of TROP2. 
mRNA microarray analysis shows the 
ten most up-regulated genes on OIV (A). 
The bar chart (B) displays the increased 
expression of TROP2 on OIV compared 
with MS (*P < .05). Immunohistochemistry 
(fluorescence microscopy, magnification 
40×) of MS (C) and OIV (D) shows TROP2+ 
cells (red, white arrow) on OIV. Dapi 
counterstaining (blue) was performed to 
visualize cell nuclei
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prostate basal cells and hepatic oval cells with stem cell charac-
teristics.30,31 Additionally, TROP2 has been found on TGF-ß1-
dependent Langerhans cells,32 its functional role in these cells 
remains however elusive. Interestingly, all the localizations of 
reported TROP2 expression (placenta, skin, epithelial carcino-
mas, fibrotic liver) have a close relation to collagen-rich ECM. 
It has so far not been detected in bone marrow or peripheral 
blood.32 Yang et al33 have shown that TROP2 is involved in the 
regulation of proliferation and differentiation of mesenchymal 
stem cells (MSCs). According to their data, TROP2 deficiency 
inhibited proliferation of MSCs and impaired differentiation by 
reducing adipogenesis and osteogenesis. Hence, they concluded 
that TROP2 expression is a crucial factor during osteogenesis 
and MSC self-renewal in particular. In the specific context of 
pathologic decrease of bone matrix mineralization which can be 
found in various metabolic bone diseases such as osteomalacia, 
chronic kidney disease-mineral bone disorder or hypophospha-
tasia, increased expression of TROP2 might act as a stimulator 
of MSC osteogenic differentiation in an attempt to improve the 
bone structure by osteoblasts.34,35
The RGD sequence of the exposed collagen fibrils that were 
identified by their typical cross-striation36 may directly be responsi-
ble for the altered differentiation of osteoclasts. RGD is a tripeptide 
amino acid sequence that occurs in proteins of the extracellular ma-
trix and is known to play a key role in integrin-mediated cell-matrix 
adhesion.37 Based on further experiments, the effect of OIV could 
be mimicked by coating MS with RGD peptides. Similarly to OIV, the 
resorption area on RGD was reduced while the depth of the single 
resorption pit showed no difference. Given the significantly lower 
number on osteoclasts on OIV, we suggest an interaction between 
the osteoclastic vitronectin receptor and the RGD peptide that could 
lead to an inhibition of osteoclastic differentiation and up-regulation 
of TROP2 expression. A further explanation for the observed effects 
might be a stronger adhesion of osteoclast precursors to the RGD 
sequence resulting in a decreased migration potential and impaired 
cytoskeletal organization which is necessary for resorption. These 
findings would be consistent with Shafieyan et al38 who differen-
tiated osteoclasts on polydimethylsiloxane coated with collagen at 
different concentrations and found an inhibition of monocyte fusion 
by high collagen densities.
While the inhibitory effect of RGD-containing proteins such as 
echistatin has been observed before, it was suggested that the occu-
pation of the vitronection receptor prevented any attachment of os-
teoclasts to the RGD peptide of the extracellular matrix and thus cell 
spreading and resorption.39-41 In our experiments, the collagen-con-
taining RGD sequences were strongly attached to the surface, sug-
gesting a direct effect on the precursor cells which challenges the 
original concept of competitive inhibition.
Another possible influence on cell differentiation could be medi-
ated by surface mechanics. The strongly decreased Young's modulus 
of OIV may therefore be in part responsible for the expression of a 
gene that is typically found in much softer tissues. However, when 
we analysed the expression of typical mechanotransduction genes 
in our samples, we could find no significant changes between MS 
and OIV (Figure S3), making this hypothesis unlikely.
A limitation of our model system is that we used dentin in-
stead of bone. However, despite their different composition and 
structure, we have shown previously that dentin and human bone 
are indistinguishable in terms of their osteoclastic resorption ac-
tivity in vitro.42 Furthermore, our osteoidosis model is based on 
demineralization of dentin, whereas osteomalacia in human bone 
results from an impaired bone metabolism and lack of mineraliza-
tion. Moreover, the extent of osteomalacia is variable among pa-
tients which might have different effects on the cells and should 
be subject of further research. Our model system is also limited 
by the fact that it leaves a number of physiological processes and 
especially the interaction between osteoclasts and osteoblasts 
unaddressed.
F I G U R E  7   TROP2 in osteomalacia 
bone biopsy. TROP2-positive 
osteoclasts (red) were also identified 
in an osteomalacia bone biopsy (C, 
fluorescence microscopy, magnification 
20×) surrounding a resorption lacuna 
(green = autofluorescence of collagen). 
Dapi counterstaining (blue) was 
performed to visualize cell nuclei. (D) 
Enlarged image section. The control 
histology of healthy bone (A, B) showed 
no TROP2-positive osteoclasts
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In conclusion, we show that a change of matrix mineralization 
alters the differentiation and function of human osteoclasts in vitro. 
The reduced number of osteoclasts and resorbed surface area was 
associated with an up-regulation of TROP2 expression on an oste-
oidosis model as well as in patients with osteomalacia, which has not 
been described so far. This is possibly due to binding of precursor 
cells to unmasked extracellular matrix proteins containing RGD se-
quences, resulting in an RGD peptide-mediated pathway. Based on 
our results, we suppose that the different surface characteristics of 
the extracellular matrix may be important for the pathophysiology 
of several metabolic bone diseases with a defect in matrix mineral-
ization such as osteomalacia, rickets, chronic kidney disease-mineral 
bone disorder or hypophosphatasia.
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